Balance Labs, Inc.
BLNC
$1.55
-$0.02-1.27%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 6,800.82% | 291.43% | |||
| Gross Profit | -6,797.54% | -291.43% | |||
| SG&A Expenses | 351.24% | -12.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5,936.19% | 166.20% | |||
| Operating Income | -5,933.35% | -166.20% | |||
| Income Before Tax | -679.51% | -2,360.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -679.51% | -2,360.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -679.51% | -2,360.44% | |||
| EBIT | -5,933.35% | -166.20% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -356.85% | -2,338.81% | |||
| Normalized Basic EPS | -87.48% | -2,500.00% | |||
| EPS Diluted | -356.85% | -1,534.00% | |||
| Normalized Diluted EPS | -87.48% | -2,500.00% | |||
| Average Basic Shares Outstanding | 70.59% | 1.53% | |||
| Average Diluted Shares Outstanding | 70.59% | 1.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||